Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles vaccine + rubella vaccine
- Development stage
- Unknown
- Lead developer
- Zydus Lifesciences
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
The Measles-Rubella vaccine is a live attenuated viral vaccine developed and marketed by Zydus Lifesciences. It is a bivalent vaccine designed to provide active immunity against both the measles virus and the rubella virus. The vaccine works by stimulating the immune system to produce antibodies and cell-mediated immune responses against the attenuated strains of the viruses. It is typically administered via subcutaneous injection as part of pediatric immunization programs to prevent measles (rubeola) and rubella (German measles) infections and their associated complications. The vaccine is part of routine pediatric immunization schedules and has received marketing authorization as a biologic product.
- Brand names
- Measles-Rubella Vaccine (Live)Measles-Rubella
- Other names
- Measles-Rubella vaccineMR vaccinemeasles and rubella vaccine (live)
Beyond the preview
Go deeper on measles vaccine + rubella vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles vaccine + rubella vaccine.